Risk factors for MI in three case–control studies
Dov Shiffman
John P. Kane
Judy Z. Louie
Andre R. Arellano
David A. Ross
Joseph J. Catanese
Mary J. Malloy
Stephen G. Ellis
James J. Devlin
10.1371/journal.pone.0002895.t001
https://plos.figshare.com/articles/dataset/_Risk_factors_for_MI_in_three_case_8211_control_studies_/594631
†<p>Data available for 254 cases.</p>‡<p>Individuals with diabetes were excluded from control group.</p>§<p>Dyslipidemia was defined in Study 1 and Study 2 to be self-reported history of a physician diagnosis of dyslipidemia or the use of lipid lowering prescription medication(s) and defined in Study 3 to be the use of lipid lowering prescription medication(s), LDL cholesterol >129 mg/dL, triglycerides >149 mg/dL or HDL cholesterol <45 mg/dL .</p>||<p>Hypertension was defined in Study 1 and Study 2 to be a self–reported history of a physician diagnosis of hypertension or use of antihypertensive prescription medication(s) and defined in Study 3 to be the use of antihypertensive prescription medication(s), systolic blood pressure >160 mmHg, or diastolic blood pressure >90 mmHg.</p><p>NA; not applicable.</p>
2013-02-21 09:45:58
mi